Ocuphire Pharma News

Ocuphire Pharma | 8-K: Current report

May 10 16:36 ET

Ocuphire Pharma | 8-K: Ocuphire Pharma Announces Financial Results for First Quarter 2024 and Provides Corporate Update

May 10 08:14 ET

Ocuphire Pharma | DEF 14A: Definitive information statements

Apr 29 17:04 ET

Ocuphire Pharma | DEFA14A: Others

Apr 29 16:46 ET

Ocuphire Pharma | PRE 14A: Preliminary proxy statements relating to merger or acquisition

Apr 19 17:30 ET

Ocuphire Pharma | 8-K: Current report

Apr 17 16:26 ET

Ocuphire Pharma | 8-K: Current report

Mar 27 16:30 ET

Ocuphire Pharma | 8-K: Ocuphire Pharma Announces Financial Results for Fourth Quarter and Full Year 2023 and Provides Corporate Update

Mar 8 08:25 ET

Ocuphire Pharma | 8-K: Current report

Feb 16 16:07 ET

Ocuphire Pharma | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Jan 11 00:00 ET

Ocuphire Pharma | S-3: Registration statement for specified transactions by certain issuers

Jan 10 00:00 ET

Ocuphire Pharma | 8-K: Current report

Dec 5, 2023 19:15 ET

Ocuphire Pharma | 8-K: Current report

Nov 27, 2023 08:45 ET

Ocuphire Pharma | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Nov 20, 2023 19:52 ET

Ocuphire Pharma | 8-K: Ocuphire Pharma Announces Financial Results for Third Quarter 2023 and Provides Corporate Update

Nov 13, 2023 08:12 ET

Ocuphire Pharma | 8-K: Current report

Nov 2, 2023 08:44 ET

Ocuphire Pharma | 8-K: Current report

Nov 1, 2023 16:21 ET

Ocuphire Pharma | 8-K: Current report

Sep 27, 2023 08:45 ET

Ocuphire Pharma | 8-K: Current report

Aug 11, 2023 09:27 ET

Ocuphire Pharma | 8-K: Current report

Aug 1, 2023 11:21 ET